SEC Comment Letter for Cocrystal Pharma, Inc. (COCP) (CIK 0001412486) (COCP) — Sep 7, 2011
Cocrystal Pharma, Inc. (COCP) (CIK 0001412486)
Date: Sept. 7, 2011 · CIK: 0001412486 · Accession: 0000000000-11-053538
AI Filing Summary & Sentiment
Reasoning
Letter
Re: BioZone Pharmaceuticals, Inc Item 4.01 Form 8- K Filed August 17, 2011 File No. 333 -146182 Dear Mr. Maza:
August 30, 2011
Elliot Maza Via Fax Chief Executive Officer and CFO BioZone Pharmaceuticals, Inc 4400 Biscayne Boulevard Miami, Florida 33137
We have completed our review of your filing . We remind you that our comments or changes to disclosure in response to our comments do not foreclose the Commission from taking any action with respect to the company or the filing and the company may not assert staff comments as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States. We urge all persons who ar e responsible for the accuracy and adequacy of the disclosure in the filing to be certain that the filing includes the information the Securities Exchange Act of 1934 and all applicable rules require. Sincerely,
/s/ Robert F Telewicz Jr. Robert F Telewicz Jr. Staff Accountant
Show Raw Text
August 30, 2011 Elliot Maza Via Fax Chief Executive Officer and CFO BioZone Pharmaceuticals, Inc 4400 Biscayne Boulevard Miami, Florida 33137 Re: BioZone Pharmaceuticals, Inc Item 4.01 Form 8- K Filed August 17, 2011 File No. 333 -146182 Dear Mr. Maza: We have completed our review of your filing . We remind you that our comments or changes to disclosure in response to our comments do not foreclose the Commission from taking any action with respect to the company or the filing and the company may not assert staff comments as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States. We urge all persons who ar e responsible for the accuracy and adequacy of the disclosure in the filing to be certain that the filing includes the information the Securities Exchange Act of 1934 and all applicable rules require. Sincerely, /s/ Robert F Telewicz Jr. Robert F Telewicz Jr. Staff Accountant